[
Effective January 1, 2015, Nasonex® will be
removed from the Select Drug Program Formulary. This change will move the drug
from tier 2 (formulary level of cost-sharing) to tier 3 (non-formulary level of
cost-sharing). Additionally, Nasonex® will require prior
authorization. Generic intranasal corticosteroids, such as fluticasone,
flunisolide and budesonide, are available at tier 1, the lowest level of
cost-sharing, with no requirement for prior authorization. While there are
over-the-counter (OTC) products available, they are not covered under the
pharmacy benefit.
Please discuss the generic intranasal corticosteroid alternatives and the
proper use of prescription and OTC products with your patients to determine the
most appropriate plan of action.
]